ACF bioanalytical plant opens as cell and gene therapies reach ‘tipping point’

By Flora Southey contact

- Last updated on GMT


Related tags: Gene

ACF Bioservices has completed the construction of its Exton, Pennsylvania, US-based facility for cell and gene product testing.

Parent company Absorption System’s Chris Bode told us the 2,400 sq. ft. site will also offer biological testing capabilities.

“We anticipate that a good portion of the site will be utilised solely for gene and cell therapies. But our core business is expanding into the emerging category of GMP biological testing, which also includes the area of non-clinical equivalence testing for small molecules.”

“We will use the facility to continue to expand our in vitro expertise to replace certain types of clinical equivalence testing for small and large molecules,” ​he told us.

According to Bode, the GMP-compliant facility was built in anticipation of client demand.

“We had conducted studies in the gene and cell therapy space for existing clients, and in order to stay in touch with these projects as they progressed further into clinical trials we needed a cGMP facility,” ​he said.

“As we explored our options, we came to the realisation that gene and cell therapies had reached a tipping point and were coming of commercial age, so to speak. Our competitive intelligence provided further evidence of commercial need for such a facility,” ​he added. 

Bode said the facility – which cost ACF Bioservices $2m (€1.7) – will attract new business.

“The complex nature of these new therapeutics (cells and genes) is pushing the limits of our historical approaches to understanding product performance,” ​he explained.

The company the opening of the facility will create 15 jobs in the next 12-18 months. 

Related news

Show more

Related products

Microsampling in Early Phase Drug Development

Microsampling in Early Phase Drug Development

Altasciences | 10-May-2022 | Technical / White Paper

Microsampling significantly lessens the volume of blood and plasma/serum that is collected and analyzed to determine circulating concentrations of therapeutic...

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 16-Feb-2022 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Partner with Experts in Precision Medicine

Partner with Experts in Precision Medicine

CellCarta | 17-Jan-2022 | Product Brochure

At CellCarta, we’re dedicated to working with our partners to further the limitless potential of precision medicine. Our broad technology offering is designed...

Related suppliers

Follow us


View more